PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
NCT ID: NCT04099134
Last Updated: 2019-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2018-10-10
2029-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223
Tumor Registry Pancreatic Cancer
NCT02089269
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717
INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
NCT04436679
Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma
NCT05248750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age =\>18 years
* written informed consent
Exclusion Criteria
* neuroendocrine pancreatic tumors
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ulm
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Seufferlein
Head of department for internal medicine I
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Seufferlein, MD
Role: PRINCIPAL_INVESTIGATOR
Ulm University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Ulm
Ulm, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PaCaReg
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.